| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |